IBA inked for three single-room proton therapy systems in U.K.

In partnership with Proton Partners International (PPI), IBA Group is bringing proton therapy to the U.K. The three systems will all be pencil beam and cone beam CT capable ProteusONE solutions, and come with a ten-year maintenance contract. A statement from IBA estimates the cost for those individual agreements to typically fall in the ballpark of 35 and 40 million euros.

ReutersDotMed